170260 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses; Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus; Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV; HIV-1, HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40
ANTIBODY AGAINST HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 P24 AND TYPE 2 P26 AND USES THEREOF
#2N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES (FOR BIOSENSING)
#3LUMINESCENT BASED ANTIGEN ASSAY
#4ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ANTIBODIES AND METHODS FOR USES THEREOF
#5CLICK CHEMISTRY AMPLIFIED NANOPORE ASSAY FOR ULTRASENSITIVE QUANTIFICATION OF PROTEINS
#6RAPID QUANTITATIVE ASSAY TO ASSESS DURATION OF INFECTION
#7EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#8IMMUNOASSAY UTILIZING TRAPPING CONJUGATE
#9Immunoassay Methods Utilizing Trapping Conjugate
#10RAPID QUANTITATIVE ASSAY TO ASSESS DURATION OF INFECTION
#11Virus-like particle (VLP) based small molecule-protein interaction trap
#12Exosome-mediated diagnosis of human immunodeficiency virus infection
#13Virus-like particle (VLP) based small molecule-protein interaction trap
#14Exosome-mediated diagnosis of hepatitis virus infections and diseases
#15Immunoassay utilizing trapping conjugate
#16Immunoassay utilizing trapping conjugate
#17Immunoassay utilizing trapping conjugate
#18Immunoassay methods utilizing trapping conjugate
#19Virus-like particle (VLP) based small molecule-protein interaction trap
#20Neutralizing GP41 antibodies and their use
#21Measuring HIV reservoirs with optical scanning
#22EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#23Exosome-mediated diagnosis of hepatitis virus infections and diseases
#24Exosome-mediated diagnosis of hepatitis virus infections and diseases
#25Neutralizing GP41 antibodies and their use
#26Improved Lateral Flow Assays
#27Self-assembled monolayers and methods for using the same in biosensing applications
#28Immunoassay methods utilizing trapping conjugate
#29Immunoassay utilizing trapping conjugate
#30METHODS FOR DETERMINING THE SUSCEPTIBILITY OF A VIRUS TO AN ATTACHMENT INHIBITOR
#31Neutralizing GP41 antibodies and their use
#32Neutralizing GP41 antibodies and their use
#33Exosome-mediated diagnosis of hepatitis virus infections and diseases
#34Inhibition of human immunodeficiency virus integrase reaching dimer formation utilizing single-chain variable antibodies
#35Self-assembled monolayers and methods for using the same in biosensing applications
#36Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance
#37Detection of HIV-related proteins in urine
#38Detection of HIV-related proteins in urine
#39ELECTROPHORETIC TAG-BASED IN VITRO ASSAY TO QUANTIFY DIMERIZATION OF P66 AND P51 SUB-UNITS OF HIV-1 REVERSE TRANSCRIPTASE (RT)
#40Compounds that Inhibit HIV Particle Formation
#41Peptides and methods of use as therapeutics and screening agents
#42Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
#43Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
#44MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE
#45Detection of HIV-related proteins in urine
#46METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS
#47Method for screening anti-HIV Drugs and a diagnostic method of AIDS
#48METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY
#49METHODS AND COMPOSITIONS FOR INHIBITING HIV INFECTION
#50Antiviral screening method to identify inhibitors of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P] binding to the HIV gag matrix (MA) protein
#51Compounds that inhibit HIV particle formation
#52Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#53Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#54Detecting early HIV infection in genital tract cells and secretions
#55Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
#56Assay for TSG101 as inhibitors of HIV production
#57Detection of proteases and screening for protease inhibitors
#58Methods and reagents for identifying inhibitors of viral protease activity
#59Protease assay for therapeutic drug monitoring
#60Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
#61TSG101 as inhibitor of HIV production
#62In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation